RSV vaccine use – the missing data

Simon Drysdale, Charles Sande, Christopher Green, Andrew Pollard

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)


Respiratory syncytial virus (RSV) infection is the most important cause of hospitalization in infants and is one of the leading global causes of infant mortality and as such its prevention through vaccination is a public health priority. While essential for the successful implementation of vaccine programs, there remains a paucity of data on the epidemiology of the virus in different settings and age groups and limited knowledge about virus transmission and the health-care costs of the disease. Such data are now needed to populate health economic models and to inform optimal approaches to disease control through vaccination.
Original languageEnglish
JournalExpert Review of Vaccines
Publication statusPublished - 2016
Externally publishedYes


Dive into the research topics of 'RSV vaccine use – the missing data'. Together they form a unique fingerprint.

Cite this